Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Firefly Neuroscience Inc AIFF

Healthcare Medical Devices
Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company dedicated to developing neuroscientific solutions that enhance outcomes for patients with mental illnesses and neurological disorders. The Company has developed its FDA-510(k) cleared Brain Network Analytics (BNA) software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches... see more

Recent & Breaking News (NDAQ:AIFF)

    Firefly Neuroscience Appoints Current Board Member, Greg Lipschitz, as Executive Chairman

    GlobeNewswire 12 hours ago

    Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update

    GlobeNewswire November 14, 2024

    Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event

    GlobeNewswire November 6, 2024

    Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    GlobeNewswire October 25, 2024

    Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data

    GlobeNewswire October 21, 2024

    Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA(TM) Technology

    GlobeNewswire October 16, 2024

    Firefly Neuroscience Announces Use of Its Brain Network Analytics Platform in Phase 1 Study of SP-624, the First Potential Treatment Designed for Women with Major Depressive Disorder

    GlobeNewswire October 15, 2024

    Firefly Neuroscience to Participate in Upcoming October Investor Conferences

    GlobeNewswire October 11, 2024

    Firefly Neuroscience Advances AI-Driven BNA(TM) Technology in Neuroscience Drug Development after Completing Successful Research Collaborations with Takeda and Novartis

    GlobeNewswire September 20, 2024

    Firefly Neuroscience Announces Partnership with Zeto to Integrate and Distribute its BNA(TM) Technology with Zeto's FDA-Cleared EEG Device Platform

    GlobeNewswire September 10, 2024

    Firefly Neuroscience Appoints Dr. Stella Vnook to its Board of Directors

    GlobeNewswire September 5, 2024

    Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright's 26th Annual Global Investment Conference September 9-11

    GlobeNewswire August 26, 2024

    Firefly Neuroscience, an AI-Driven Brain Health Company, to Host Shareholder Update Call on September 4th

    GlobeNewswire August 22, 2024

    Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management for Patients with Cognitive Disorders

    GlobeNewswire August 21, 2024

    UPDATE -- Firefly Neuroscience CEO Issues Letter to Stockholders Following Closing of Merger and Listing on Nasdaq

    GlobeNewswire August 13, 2024

    Firefly Neuroscience CEO Issues Letter to Stockholders Following Closing of Merger and Listing on Nasdaq

    GlobeNewswire August 13, 2024